Evelyn Carone

Evelyn Carone serves as Chief Technology Officer at Ivy Fertility. Ivy Fertility operates in the medical practice sector with approximately 52.0 employees. The company is headquartered in California.

Industry & Role Insights

• • MessageCEO tracks 878 executives in the medical practice sector.
• • 13,742 executive contacts are available in California.
• • Our database includes 201,464 c suite-level executives.

Cloudflare DNS Amazon SES Outlook CloudFlare Hosting Mobile Friendly Squarespace ECommerce Typekit Basis Sisense Splunk KNIME Domo

medical practices ivf in vitro fertilization fertility treatment iui intrauterine insemination fertility preservation egg donation surrogacy embryo cryopreservation donor eggs fertility testing hormonal assessments sperm analysis preimplantation genetic testing pgt-a pgt-m lgbtq+ family building reproductive endocrinology cryopreservation fertility center patient care genetic screening third-party reproduction ovulation stimulation egg retrieval embryo transfer patient education individualized treatment donor database frozen eggs fresh eggs embryology sperm donors egg donor services reproductive health genetic counseling success rates fertility support hysterosalpingogram fertility diagnostics family building options egg freezing sperm freezing comprehensive care diagnosis & treatment patient empowerment high-quality fertility services emotional support medical oversight egg quality evaluation hospital & health care

GA

Ghassan Abboud president and CEO at 1st Family Dental

MD

Mark Danzo CEO at 20/20 Institute

PS

Paul Smullen Chief Technology Officer at 21D Clinical Limited

YT

Yuansheng Tan Chief Technology Officer at 21st Century Medicine

DW

David Watson Executive VP & CFO at 21st Century Oncology

Outreach Guidance — medical practice Sector

Executives like Evelyn Carone in the medical practice sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Ivy Fertility.

Evelyn Carone's Position in the MessageCEO Database

• •Evelyn Carone is 1 of 1 verified executive contact we track at Ivy Fertility.
• •841 verified executive contacts in medical practice are in the MessageCEO database.
• •12,900 verified executive contacts in California are in the database.
• •7 verified contacts work at medical practice companies in the 52.0 employee range (same size as Ivy Fertility).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated November 2026.

How do I reach Evelyn Carone directly?

Evelyn Carone's verified email address is available to MessageCEO Pro subscribers. They currently serve as Chief Technology Officer at Ivy Fertility. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Evelyn Carone work for?

Evelyn Carone is Chief Technology Officer at Ivy Fertility, a company in the medical practice sector with 52.0 employees. The company is based in California.

Can I pitch or sell to Evelyn Carone?

As Chief Technology Officer at Ivy Fertility, Evelyn Carone is a key decision-maker in the medical practice sector. MessageCEO Pro gives you verified email to reach Evelyn Carone directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Evelyn Carone in?

Evelyn Carone works in the medical practice industry as Chief Technology Officer at Ivy Fertility. MessageCEO provides verified contact information for executives across all major industries.

Is Evelyn Carone's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Evelyn Carone's profile is kept up-to-date with the latest available information.

Last updated: November 2, 2026